Direct correction of haemoglobin E β-thalassaemia using base editors

Authors:

Abstract
Haemoglobin E (HbE) β-thalassaemia causes approximately 50% of all severe thalassaemia worldwide; equating to around 30,000 births per year. HbE β-thalassaemia is due to a point mutation in codon 26 of the human HBB gene on one allele (GAG; glutamatic acid → AAG; lysine, E26K), and any mutation causing severe β-thalassaemia on the other. When inherited together in compound heterozygosity these mutations can cause a severe thalassaemic phenotype. However, if only one allele is mutated individuals are carriers for the respective mutation and have an asymptomatic phenotype (β-thalassaemia trait). Here we describe a base editing strategy which corrects the HbE mutation either to wildtype (WT) or a normal variant haemoglobin (E26G) known as Hb Aubenas and thereby recreates the asymptomatic trait phenotype. We have achieved editing efficiencies in excess of 90% in primary human CD34 + cells. We demonstrate editing of long-term repopulating haematopoietic stem cells (LT-HSCs) using serial xenotransplantation in NSG mice. We have profiled the off-target effects using a combination of circularization for in vitro reporting of cleavage effects by sequencing (CIRCLE-seq) and deep targeted capture and have developed machine-learning based methods to predict functional effects of candidate off-target mutations.
Funding Information
  • RCUK | Medical Research Council (MC_PC_15069, MC_UU_00029/04)
  • DH | NIHR | Health Services Research Programme (NIHR203339, NIHR203311)
  • Wellcome Trust (225220/Z/22/Z, 102176/B/13/Z, 211122/Z/18, 225220/Z/22/Z)
  • RCUK | MRC | Medical Research Foundation (MR/P019633/1, MR/R008108, MR/T030410/1, MC_UU_00016/14)
  • DH | National Institute for Health Research (NIHR203311)

This publication has 32 references indexed in Scilit: